Applications Published 10 January 2001
Published: 25-Aug-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Polyalkoxy copolymers as lipase inhibitors and their compsns
Procter & Gamble 1066025*Pharmaceutical compsn of topiramate
Ortho-McNeil Pharmaceutical 1066027*Methods and devices for modulating the immune response
Applied Vaccine Technologies 1066028*Peroral active agent suspension
Boehringer Ingelheim Pharma 1066029*Topical hormonal compsn with systemic effect
Laboratoires Theramex 1066030*Method fro the production of microcapsules
Aventis Research & Technologies 1066031*Sachet formulations
Biovail Technologies 1066032*Smilagenin and anzurogenin-D for the treatment of Alzheimer's disease
Phytopharm 1066033*Oxy-vanadium (IV) complexes having spermicidal activity
Parker Hughes Institute 1066034*Substituted aromatic compounds for treatment of antibiotic resistant infections
Department of the Army, US Government 1066035*Agents with serotonin-related activity for the treatment of sleep apnoea
The Board of Trustees of the University of Illinois 1066036*Indole-2,3-dione-3-oxime derivatives for therapeutic use
Neurosearch 1066037*Use of cabergoline in the treatment of restless legs syndrome
Pharmacia & Upjohn 1066038*Substituted quinazolines and analogues and the use thereof
CoCensys 1066039*Pharmaceutical compsn containing cefuroxime axetil stable for moisture retention
Daewoong Pharmaceutical 1066040*The use of estradiol derivatives for treating side-effects during and/or after GNRHA therapy
Jenapharm 1066041*Steroidal saponins for treating Alzheimer's disease
Phytopharm 1066042*Materials and methods relating to the treatment of conditions involving mast cells, basophils and eosinophils
University College London 1066043*Dextran formulations and method for treatment of inflammatory joint disorders
Glenpharma 1066044*Mammalian-derived peptides for the treatment of microbial infection
Theragem 1066045*Compsn for pharmaceutical use and/or for use as a nutritional supplement, for humans and animals
Dr Schieffer Arznemittel 1066046*Methods and materials for treating inflammatory diseases
Mayo Foundation for Medical Education and Research 1066047*A pharmaceutical preparation comprising angiotensin II type 2 receptor agonist, and use thereof
A+Science Invest 1066048*Pharmaceutical compsns for prolonged peptide release and preparation method
Societe de Conseils de Recherche et d'Applications Scientifiques 1066049*Application of HSP70 proteins
Multhof, Gabriele 1066050*Sciellin and uses thereof
The General Hospital Corp 1066051*Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
Osiris Therapeutics 1066052*HIB/DTPA vaccine compsn and methods of preparation
SmithKline Beecham Biologicals 1066053*Use of active P40 conujgates for nasal delivery
Pierre Fabre Medicament 1066054*Adjuvant-containing vaccines
Merial 1066055*An iron-dextran compound for use as a component in a therapeutical compsn for prophylaxis or treatment of iron deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administratable therapeutical compsn
Pharmacosmos Holding 1066056*Haemoglobin-polysaccharide conjugates
Hemosol 1066057*Methods and means for the treatment of immune related diseases
Immunotoko 1066058*Formulations for protection of PEG-interferon alpha conjugates
Schering 1066059*Mesenchymal stem cells as immunosuppressants
Osiris Therapeutics 1066060*Use of scatter factor to enhance angiogenesis
Long Island Jewish Medical Centre 1066061*A method for treating contaminated products and articles
Nokuta 1066062*Dispensing means
Quest International 1066063*Metered dose inhaler agitator
IEP Pharmaceutical Devices 1066072*Drug delivery devices
Bespak 1066073*Aerosolised active agent delivery
Inhale Therapeutic Systems 1066074*Inhalation device
AstraZeneca 1066075*Novel local anaesthetic compounds and uses
Advanced Medicine 1066245*Methyl-phenyl derivatives, preparation method and use
Sanofi-Synthelabo 1066248*A convergent synthesis of alpha-aryl-beta ketonitriles
Du Pont Pharmaceuticals 1066250*A process of controlling particle size of naphthaquinone diazide esters
Clariant International 1066252*
